23andMe (ME) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

23andMe (ME)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

0.61

-0.00 (0.00%)

as of Mar 28, 2025, 12:00:00 am Market Open.

7 watching

BUY ON WEAKNESS

He's shocked this is so low. Glaxo should buy them. At $2, the risk is priced in. Buy.

BUY

It's a genetic testing company with subscription services to let you know how your genes could effect your health. They went public last June, but has fallen since from $11 to $8. He doesn't understand why. Gene sequencing is the future of medicine and this company holds a treasure trove of data (kept private) that could be applied in medicine.

Showing 1 to 2 of 2 entries

23andMe (ME) Frequently Asked Questions

What is 23andMe stock symbol?

23andMe is a American stock, trading under the symbol ME (previously ME-Q on Stockchase) on the NASDAQ (ME). It is usually referred to as NASDAQ:ME or ME

Is 23andMe a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on ME (previously ME-Q on Stockchase) on Stockchase. Read the latest expert commentary for 23andMe.

Is 23andMe a good investment or a top pick?

23andMe was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for 23andMe.

Why is 23andMe stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for 23andMe.

Is 23andMe worth watching?

23andMe is followed by 7 investors on Stockchase and is a trending stock that is worth watching.

What is 23andMe stock price?

On 2025-03-28, 23andMe (ME) stock closed at a price of $0.61.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Richard Orrell

RN Croft Financial Group

Stockchase Insights

5i Research

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale